Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone + fluconazole mouthwash for oral lichen planus
IRCT20250715066509N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone and fluconazole in oral lichen planus (OLP) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Severity of oral lichen planus lesions. Started Sep 2025; status: completed.
02
Drugs
dexamethasonefluconazole
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT20250715066509N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250715066509N1.